aminoglutethimide has been researched along with Lupus Erythematosus, Systemic in 3 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McCraken, M | 1 |
Benson, EA | 1 |
Hickling, P | 2 |
Etherington, J | 1 |
Haynes, P | 1 |
Buchanan, N | 1 |
3 other studies available for aminoglutethimide and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Systemic lupus erythematosus induced by aminoglutethimide.
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged | 1980 |
Dual pharmacological effect of aminoglutethamide.
Topics: Aminoglutethimide; Breast Neoplasms; Female; Humans; Lupus Erythematosus, Systemic | 1994 |
Effect of aminoglutethemide on the activity of a case of a connective tissue disorder with features of systemic lupus erythematosus.
Topics: Aged; Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Connective Tissue Diseases; Female; | 1993 |